Production (Stage)
Perspective Therapeutics, Inc.
CATX
$2.39
-$0.12-4.78%
AMEX
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Net Income | -18.18M | -40.17M | -15.12M | -11.70M | -12.28M |
| Total Depreciation and Amortization | 732.00K | 1.41M | 669.00K | 572.00K | 356.00K |
| Total Amortization of Deferred Charges | -- | 7.00K | -- | -- | -- |
| Total Other Non-Cash Items | 1.25M | 24.29M | 1.47M | 738.00K | 380.00K |
| Change in Net Operating Assets | -5.38M | -11.44M | 16.35M | 1.49M | 25.40M |
| Cash from Operations | -21.58M | -26.61M | 3.37M | -8.90M | 13.85M |
| Capital Expenditure | -4.66M | -14.61M | -29.71M | -1.02M | -9.07M |
| Sale of Property, Plant, and Equipment | -- | 335.00K | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -909.00K | -124.32M | -24.00K | -2.28M | -38.23M |
| Cash from Investing | -5.57M | -138.60M | -29.74M | -3.30M | -47.30M |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -13.00K | -12.00K | -16.00K | -8.00K | -12.00K |
| Issuance of Common Stock | 9.99M | -- | 644.00K | 122.09M | 166.34M |
| Repurchase of Common Stock | -- | -287.34M | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | 288.06M | -- | -- | -- |
| Cash from Financing | 9.97M | 345.00K | 628.00K | 122.08M | 166.33M |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -17.17M | -164.86M | -25.74M | 109.89M | 132.88M |